Big Gain For Cleveland BioLabs, Inc.

Fri 06 Mar 20 at 05:30 PM

Cleveland BioLabs, Inc. (CBLI:NASDAQ) soared at $3.6, representing a gain of 24.6%. From Thu 20 Feb 20, the stock recorded 60.00% Up Days and 54.55% Green Days

The stock spiked on Thu 27 Feb 20 at $5 with a volume of 6M+.

About Cleveland BioLabs, Inc. (CBLI:NASDAQ)

Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.

Top 10 Gainers:

Spherix Incorporated (SPEX:NASDAQ), 130.99%
Digirad Corporation (DRAD:NASDAQ), 114.42%
Tocagen Inc. (TOCA:NASDAQ), 56.52%
Enzo Biochem, Inc. (ENZ:NYSE), 50.44%
Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 43.78%
NanoViricides, Inc. (NNVC:NYSEMKT), 38.49%
Menlo Therapeutics Inc. (MNLO:NASDAQ), 26.91%
TEGNA Inc. (TGNA:NYSE), 26.49%
Cleveland BioLabs, Inc. (CBLI:NASDAQ), 24.57%
iFresh Inc. (IFMK:NASDAQ), 24.54%